Minoryx Therapeutics BE
- 0713.984.534
- BE0713984534
- Avenue Jean Mermoz 32, 6041 Charleroi
- See the 3 companies at this address
- 28 November 2018
Profile
Official information from the CBE (FPS Economy).
Minoryx Therapeutics BE is a Belgian company (Société anonyme) whose registered office is established at 6041 Charleroi. Its main activity falls under “Recherche-développement en biotechnologie” (NACE 72101).
- Legal form
- Société anonyme
- Legal situation
- Situation normale
- Date of incorporation
- 28 November 2018
- Main activity (NACE)
- 72101Recherche-développement en biotechnologie
An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more
Secondary activities
11 additional NACE codes declared.
- 72109Recherche-développement en autres sciences physiques et naturelles
- 74999Autres activités des professions libérales et autres activités scientifiques et techniques, nca
- 71209Autres activités de contrôle et analyses techniques
- 72109Recherche-développement en autres sciences physiques et naturelles
- 21100Fabrication de produits pharmaceutiques de base
- 72190Recherche-développement en autres sciences physiques et naturelles
- 21100Fabrication de produits pharmaceutiques de base
- 72190Recherche-développement en autres sciences physiques et naturelles
Your risk analysis on this company
AML Company ran Minoryx Therapeutics BE through your due diligence questionnaire. Here are the first findings.
What is the geographic exposure of the client and of its transactions?
Belgium only· Registered office published in the register
What is the company's solvency and lifecycle status?
Trading, no proceedings· Legal situation published in the register
Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.
Run the full analysisThis preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.
Establishments
1 active establishment unit declared with the CBE.
Finances & financial health
Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).
Equity & result
| Financial year | Equity | Result | Turnover / gross margin | Headcount (FTE) |
|---|---|---|---|---|
| 2025 | €2,553,974 | -€1,087,747 | €242,408gross margin | 4,8 |
| 2022 | €4,921,357 | -€1,436,555 | -€48,697gross margin | 3,8 |
| 2021 | €4,349,082 | -€1,377,732 | -€172,534gross margin | 4,6 |
| 2020 | – | – | - | – |
Financial ratios
Solvency, liquidity and profitability, computed year by year from the filed annual accounts.
Equity / balance sheet total
Current assets / debts due within one year
This year's filing does not carry the item the calculation needs.
Result for the year / turnover
This year's filing does not carry the item the calculation needs.
Operating result / turnover
Debts due after one year / balance sheet total
Result for the year / equity
Balance sheet structure
| Ratio | 2025 | 2022 | 2021 | Trend |
|---|---|---|---|---|
| Solvency | 66% 13% | 79% 5,6% | 73,3% | |
| Liquidity | 4,17 x 3,75 | 0,43 x 0,4 | 0,03 x | |
| Net margin | - | - | - | - |
| Operating margin | - | - | - | - |
| Long-term debt | 27,7% 20,6% | 7,1% 2,5% | 4,6% | |
| Return on equity | -42,6% 13,4% | -29,2% 2,5% | -31,7% |
Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.
Filing history (6)▾
| Financial year | Filing | Filing type | Model | Source |
|---|---|---|---|---|
| 01/01/2025 → 31/12/2025 | 22/07/2026 | Initial | m01-f | BNB |
| 01/01/2022 → 31/12/2022 | 27/06/2023 | Initial | m01-f | BNB |
| 01/01/2021 → 31/12/2021 | 13/07/2022 | Initial | m01-f | BNB |
| 01/01/2020 → 31/12/2020 | 22/07/2021 | Initial | m07-f | BNB |
| 01/01/2019 → 31/12/2019 | 12/07/2020 | Initial | m07-f | BNB |
| 02/11/2018 → 31/12/2018 | 28/06/2019 | Initial | m01-f | BNB |
Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.
The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.
Notices in the Belgian Official Gazette
Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.
- SIEGE SOCIAL23 March 2023
- DEMISSIONS, NOMINATIONS13 December 2021
Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.
Frequently asked questions about Minoryx Therapeutics BE
Quick answers on Minoryx Therapeutics BE's identity, contact details and official CBE information.
What is Minoryx Therapeutics BE's enterprise number (CBE)?
What is Minoryx Therapeutics BE's VAT number?
Where is Minoryx Therapeutics BE's registered office?
What is Minoryx Therapeutics BE's legal form?
When was Minoryx Therapeutics BE incorporated?
Is Minoryx Therapeutics BE still active?
What is Minoryx Therapeutics BE's main activity?
How many establishments does Minoryx Therapeutics BE have?
Has Minoryx Therapeutics BE filed its annual accounts?
Which official notices concern Minoryx Therapeutics BE?
Is Minoryx Therapeutics BE subject to anti-money-laundering obligations in Belgium?
Company timeline
Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.
10 AI-analysed dimensions are not shown.
- 2026
- 22 July 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m01-fFiled accounts2026-00315523
- 2023
- 12 December 2023Articles of association · Capital · Shares · Appointments · ResignationsView the notice23455066
- 27 June 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m01-fFiled accounts2023-00162471
- 2022
- 13 July 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m01-fFiled accounts2022-20178918
- 2021
- 22 July 2021Annual accounts filed·Financial year ended 31 December 2020 · Model m07-fFiled accounts2021-38000444
- 2020
- 12 July 2020Annual accounts filed·Financial year ended 31 December 2019 · Model m07-fFiled accounts2020-28200272
- 2019
Registry record since 7 September 2026
The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.
AI extraction of strategic AML data
The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.
- Legal life
- Restructuring
- Capital
- Legal form
- Incorporation
- Directors
- Beneficial owners
- Registered office
- Company name
- Notarial deeds
Similar companies
Same business sector and geographic area.
Stellaris
Brussels South Charleroi BioPark Dev
ENDO TOOLS THERAPEUTICS
LOVAT FRASER CONSULTING
NATHOLA
Immunofusion
Nexelis Europe
CENTRE DE RECHERCHE EN AERONAUTIQUE
CENTRE D'EXCELLENCE EN TECHNOLOGIES DE L'INFORMATION ET DE LA COMMUNICATION
Step it up
Full analysis unlocked.
Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.